NO963818D0 - Forhöyet sekresjon av polypeptider - Google Patents

Forhöyet sekresjon av polypeptider

Info

Publication number
NO963818D0
NO963818D0 NO963818A NO963818A NO963818D0 NO 963818 D0 NO963818 D0 NO 963818D0 NO 963818 A NO963818 A NO 963818A NO 963818 A NO963818 A NO 963818A NO 963818 D0 NO963818 D0 NO 963818D0
Authority
NO
Norway
Prior art keywords
polypeptides
increased secretion
secretion
increased
Prior art date
Application number
NO963818A
Other languages
English (en)
Other versions
NO963818L (no
Inventor
Shi-Yuan Meng
Charles F Morris
Larry B Tsai
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of NO963818D0 publication Critical patent/NO963818D0/no
Publication of NO963818L publication Critical patent/NO963818L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
NO963818A 1994-03-18 1996-09-12 Forhöyet utskillelse av polypeptider NO963818L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/215,138 US5470719A (en) 1994-03-18 1994-03-18 Modified OmpA signal sequence for enhanced secretion of polypeptides
PCT/US1995/003175 WO1995025743A1 (en) 1994-03-18 1995-03-16 Enhanced secretion of polypeptides

Publications (2)

Publication Number Publication Date
NO963818D0 true NO963818D0 (no) 1996-09-12
NO963818L NO963818L (no) 1996-11-15

Family

ID=22801818

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963818A NO963818L (no) 1994-03-18 1996-09-12 Forhöyet utskillelse av polypeptider

Country Status (15)

Country Link
US (2) US5470719A (no)
EP (1) EP0750634A1 (no)
JP (1) JPH09510611A (no)
AU (1) AU689569B2 (no)
CA (1) CA2185343A1 (no)
CZ (1) CZ284204B6 (no)
FI (1) FI963655A (no)
HU (1) HUT76674A (no)
IL (1) IL112982A0 (no)
MX (1) MX9604047A (no)
NO (1) NO963818L (no)
NZ (1) NZ283214A (no)
SK (1) SK116896A3 (no)
WO (1) WO1995025743A1 (no)
ZA (1) ZA952218B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747662A (en) * 1995-03-01 1998-05-05 Genentech, Inc. Methods and compositions for secretion of heterologous polypeptides
US5885820A (en) * 1996-01-31 1999-03-23 St. Louis University Clone of a nucleotide sequence encoding a protein having two functions
US20020065394A1 (en) * 1998-03-18 2002-05-30 Kenneth Jacobs Secreted proteins and polynucleotides encoding them
KR100360594B1 (ko) * 2000-01-19 2002-11-13 한미약품공업 주식회사 인간 인터페론 알파의 발현 분비벡터 및 이를 이용한인터페론 알파의 생산 방법
AU2001275267A1 (en) 2000-06-05 2001-12-17 Corixa Corporation Leader peptides for enhancing secretion of recombinant protein from a host cell
CN1897977A (zh) * 2003-10-20 2007-01-17 Ns基因公司 帕金森氏病的体内基因治疗
WO2007137300A2 (en) 2006-05-23 2007-11-29 Bellicum Pharmaceuticals, Inc. Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
US8097422B2 (en) 2007-06-20 2012-01-17 Salk Institute For Biological Studies Kir channel modulators
US20090280103A1 (en) * 2008-04-04 2009-11-12 Martin Flueck Regulation of muscle repair
WO2010033229A2 (en) * 2008-09-22 2010-03-25 Calmune Corporation Methods and vectors for display of molecules and displayed molecules and collections
CN102482638A (zh) 2009-07-02 2012-05-30 微德赞股份有限公司 制备己二酸的生物学方法
US20120184007A1 (en) * 2009-07-09 2012-07-19 Stephen Picataggio Engineered microorganisms with enhanced fermentation activity
US8889394B2 (en) * 2009-09-07 2014-11-18 Empire Technology Development Llc Multiple domain proteins
US8728798B2 (en) 2011-05-03 2014-05-20 Verdezyne, Inc. Biological methods for preparing adipic acid
US8343752B2 (en) 2011-05-03 2013-01-01 Verdezyne, Inc. Biological methods for preparing adipic acid
MY184871A (en) 2011-07-06 2021-04-28 Radici Chimica S P A Biological methods for preparing a fatty dicarboxylic acid
US9909151B2 (en) 2012-12-19 2018-03-06 Verdezyne, Inc. Biological methods for preparing a fatty dicarboxylic acid
WO2014100504A2 (en) 2012-12-19 2014-06-26 Verdezyne, Inc. Biological methods for preparing a fatty dicarboxylic acid
DK3129493T3 (da) 2014-04-09 2021-09-27 Scripps Research Inst Import af unaturlige eller modificerede nukleosidtriphosphater ind i celler via nukleinsyre-triphosphat-transportører
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US20180148744A1 (en) 2015-03-20 2018-05-31 Verdezyne, Inc. Biological methods for preparing 3-hydroxypropionic acid
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
EP3652316A4 (en) 2017-07-11 2021-04-07 Synthorx, Inc. INTEGRATION OF NON-NATURAL NUCLEOTIDES AND METHOD FOR THEREFORE
WO2019014309A1 (en) 2017-07-13 2019-01-17 Verdezyne (Abc), Llc BIOLOGICAL METHODS FOR MODIFYING A CELL CARBON FLOW
BR112020002271A2 (pt) 2017-08-03 2020-07-28 Synthorx, Inc. conjugados de citocina para o tratamento de doenças proliferativas e infecciosas
CN108610398B (zh) * 2018-01-15 2020-08-11 武汉海特生物制药股份有限公司 一段功能序列及在分泌蛋白表达中的应用
WO2020060948A1 (en) 2018-09-17 2020-03-26 Levadura Biotechnology, Inc. Production of cannabinoids in yeast using a fatty acid feedstock
WO2020163532A1 (en) 2019-02-06 2020-08-13 Synthorx, Inc. Il-2 conjugates and methods of use thereof
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
US4757013A (en) * 1983-07-25 1988-07-12 The Research Foundation Of State University Of New York Cloning vehicles for polypeptide expression in microbial hosts
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
ES2093112T3 (es) * 1990-09-25 1996-12-16 Genentech Inc Nuevo factor neurotrofico.
WO1993008300A1 (en) * 1991-10-18 1993-04-29 The University Of Calgary Expression-secretion vectors for the production of biologically active fv fragments
AU4535993A (en) * 1992-06-12 1994-01-04 Regeneron Pharmaceuticals, Inc. Therapeutic and diagnostic methods based on neurotrophin-4 expression
US5474914A (en) * 1992-07-29 1995-12-12 Chiron Corporation Method of producing secreted CMV glycoprotein H

Also Published As

Publication number Publication date
MX9604047A (es) 1997-09-30
EP0750634A1 (en) 1997-01-02
NO963818L (no) 1996-11-15
US5608036A (en) 1997-03-04
CZ284204B6 (cs) 1998-09-16
ZA952218B (en) 1995-12-12
IL112982A0 (en) 1995-06-29
AU2119895A (en) 1995-10-09
NZ283214A (en) 1998-03-25
JPH09510611A (ja) 1997-10-28
FI963655A (fi) 1996-11-15
AU689569B2 (en) 1998-04-02
CA2185343A1 (en) 1995-09-28
HUT76674A (en) 1997-10-28
CZ264496A3 (en) 1997-05-14
US5470719A (en) 1995-11-28
WO1995025743A1 (en) 1995-09-28
SK116896A3 (en) 1997-08-06
FI963655A0 (fi) 1996-09-16
HU9602548D0 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
NO963818D0 (no) Forhöyet sekresjon av polypeptider
FI951579A0 (fi) Paneelimaisten osien liitosrakenne
ID15880A (id) Bentuk baru heteroaril oksazolidinon-oksazolidinon
NO972494L (no) Nye pinnsvin-avledede polypeptider
FI930897A0 (fi) Protein zp3 av ytterskiktet av maenniskans aeggcell
DE69411533D1 (de) Schutzbalg
FI940751A (fi) Alusrakenteen päällystäminen
DE69520771T2 (de) Faltenbalg
FI935592A (fi) Menetelmä polypeptidien valmistamiseksi
DE9414208U1 (de) Beschlagunterteil
NO991148D0 (no) Fremstilling av 1-butyl-4-piperidinyl-metylamin
DE29613006U1 (de) Rollbalg
DE69413381D1 (de) Schutzbalg
DE69434900D1 (de) Menschliche chemokin-polypeptide
FI971888A0 (fi) Ohjausaste
FI1513U1 (fi) Anordning foer insaettning av produkter i foersaeljnings- och exponeringsstaell
DE59402920D1 (de) Wellenbalg
DE9401167U1 (de) Faltenbalg
DE29517199U1 (de) Keramisches Wandverkleidungselement
KR970007616U (ko) 리모터콘트롤의 회로
KR950034565U (ko) 캠코더의 텔레와이드 스위치 구조
SE9502007D0 (sv) Novel polypeptides
UA644S (uk) Мікро-еом широкого призначення
SE9600037D0 (sv) Modifiering av cement
KR960015533U (ko) 스위치의 구조